Perbedaan Organon Pharma Indonesia Tbk. dan Damai Sejahtera Abadi Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Damai Sejahtera Abadi Tbk. diperdagangkan di Rp145 (kapitalisasi pasar 423,15 M, volume 24 jam 5,35 jt). Perbedaan utamanya: Damai Sejahtera Abadi Tbk. jauh lebih besar — sekitar 4,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | UFOE | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 423,15 M |
Volume | — | 5,35 jt |
Lot | — | 53,47 rb |
Perputaran | — | 805,82 jt |
Harga Rata-rata | — | 150,7 |
Nilai Transaksi | — | 805,82 jt |
Harga Ekuilibrium Indikatif | — | 145 |
Volume Ekuilibrium Indikatif | — | 277 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Damai Sejahtera Abadi Tbk (the Company) was established in Surabaya based on Notarial Deed No. 46 of Setiawati Sabarudin, S.H., Notary in Surabaya, dated January 29, 2004. The Company’s immediate parent company is PT Damai Sejahtera Lestari, which is ultimately owned by Mr. Pudji Harianto and Mr. Poedji Harixon.
Selengkapnya di halaman UFOE →